ÂÜÀòÂÒÂ×

Dan Peer is an accomplished professional with extensive experience in research and biotechnology. As the Founder and Chairman of the Board at NeoVac since September 2021, Dan also holds key positions at Ramot - Tel Aviv University's Tech Transfer Arm and TAU Ventures as a Board Member and former Chairman. Dan serves as Vice President for Research and Development and Professor at Tel Aviv University, overseeing the Laboratory of Precision Nanomedicine. Additional roles include Managing Director of the Center for Translational Medicine at ART BioScience and founding board member of SEPL Pharma and Quiet Therapeutics. Dan's academic credentials include a Ph.D. in Biochemistry/Biophysics from Tel Aviv University and a postdoctoral fellowship at Harvard Medical School.